|
| |
Journal Article List
Most of these references were taken from "Idiopathic
Thrombocytopenic Purpura: A Practice Guideline Developed by Explicit Methods for
The American Society of Hematology".
Additional headings include: ITP in Children, ITP and Pregnancy, ITP in Adults, Gammaglobulin (IVIg),
Splenectomy, Methylprednisone, Other Treatments.
General Information
Kurata Y, Miyagawa S, Kosugi S, Kashiwagi H, Honda S, Mizutani
H,Tomiyama Y, Kanakyama Y, Matsuzawa Y: High-titer antinuclear
antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP
antibodies in patients with idiopathic thrombocytopenic purpura.
Thromb Haemost 71:184, 1994
Stasi R, Stipa E, Masi M, Oliva F, Sciarra A, Perrotti A,
Olivieri M, Zaccari G, Gandolfo GM, Galli M, Barbui T, Papa G:
Prevalence and clinical significance of elevated antiphospholipid
antibodies in patients with idiopathic thrombocytopenic purpura.
Blood 84:4203, 1994
Department of Clinical Epidemiology and Biostatistics MU,
Hamilton: How to read clinical journals. III. To learn the
clinical course and prognosis of disease. Can Med Assoc J
124:869, 1981
Department of Clinical Epidemiology and Biostatistics MU,
Hamilton: How to read clinical journals. To distinguish useful
from useless or even harmful therapy. Can Med Assoc J 124:1156,
1981
Sackett DL: Rules of evidence and clinical recommendation on
the use of antithrombotic drugs. Chest 95:25, 1989 (suppl)
Cook DJ, Guyatt GH, Laupacis A, Sackett DL: Rules of evidence
and clinical recommendations on the use of antithrombotic agents.
Chest 102:305S, 1992
Guyett GH, Sackett DL, Cook DJ: User's guide to the medical
literature. II. How to use an article about therapy or
prevention. A. Are the results of the study valid? JAMA 270:2598,
1993
Park RE, Fink A, Brook RH: Physician ratings for appropriate
indications for six medical and surgical procedures. Am J Public
Health 76:766, 1986
Brook RH, Chassin M, Fink A, Solomon D: A Method for the
Detailed Assessment of the Appropriateness of Medical
Technologies. A RAND Note. N-3376-HHS. Santa Monica, CA, RAND
Corp, 1991
Centers for Disease Control and Prevention: Recommendations of
the Advisory Committee on Immunization Practices: Use of vaccines
and immune globulins in persons with altered immunocompetence.
MMWR Morbid Mortal Wkly Rep 42:1, 1993
Eyster ME, Rabkin CS, Hilgartner MW, Aledort LM, Ragni MV,
Sprandio J, White GC, Eichinger S, De Moerloose P, Andes WA,
Cohen AR, Manco-Johnson M, Bray GL, Schramm W, Hatzakis A,
Lederman MM, Kessler CM, Goedert JJ: Human immunodeficiency
virus-related conditions in children and adults with hemophilia:
rates, relationship to CD4 counts, and predictive value. Blood
81:828, 1993
Payne BA, Pierre RV: Pseudothrombocytopenia: A laboratory
artifact with potentially serious consequences. Mayo Clin Proc
59:123, 1984
Savage RA: Pseudoleukocytosis due to EDTA-induced platelet
clumping. Am J Clin Pathol 81:317, 1984
Vicari A, Banfi G, Bonini PA: EDTA-dependent
pseudothrombocytopaenia: A 12-month epidemiological study. Scand
J Clin Lab Invest 48:537, 1988
Garcia Suarez J, Calero MA, Ricard MP, Krsnik I, Rus GP,
Perera F, Merino JL: EDTA-dependent pseudothrombocytopenia in
ambulatory patients: Clinical characteristics and role of new
automated cell-counting in its detection. Am J Hematol 39:146,
1992
Najean Y, Lecompte T: Chronic pure thrombocytopenia in elderly
patients: An aspect of the myelodysplastic syndrome. Cancer
64:2506, 1989
Zeller M: Rheumatoid arthritis: Food allergy as a factor. Ann.
Allerg. 7: 200-239, 1949.
Zussman BM: Food hypersensitivity simulating rheumatoid
arthritis. South Med.J. 59: 935-939, 1966.
Skoldstam L, Larsson L, and Lindstrom F: Effects of fasting
and lactovegetarian diet on rheumatoid arthritis. Scand. J.
Rheum. 8: 249-255, 1979.
Parke AL, Hughes GRV: Rheumatoid arthritis and food: A case
study. Br. Med. J. 282: 2027-2029, 1981.
Little CH, Stewart AG, Fennessy MR: Platelet serotonin release
in rheumatoid arthritis: A study in food-intolerant patients.
Lancet 297-299, 1983.
Kremer JM, Bigauoette J, Michalek AV, et al: Effects of
manipulation of dietary fatty acids on clinical manifestations of
rheumatoid arthritis. lancet 184-187, 1985.
Ratner D, Esgel E, Vigder K: Juvenile rheumatoid arthritis and
milk allergy. J. Roy. Soc. Med. 78: 410-413, 1985.
Darlington LG, Ramsey NW, Mansfield JR: Placebo controlled,
blind study of dietary manipulation therapy in rheumatoid
arthritis. Lancet 236-238, 1986.
Komrower GM, Watson GH: Prognosis in idiopathic
thrombocytopenic purpura of childhood. Arch Dis Child 29:502,
1954
Choi SI, McClure PD: Idiopathic thrombocytopenic purpura in
childhood. Can Med Assoc J 97:562, 1967
Walker RW, Walker W: Idiopathic thrombocytopenia, initial
illness and long term follow up. Arch Dis Child 59:316, 1984
Ramos MEG, Newman AJ, Gross S: Chronic thrombocytopenia in
childhood. Pediatrics 92:584, 1978
Lusher JM, Zuelzer WW: Idiopathic thrombocytopenic purpura in
childhood. J Pediatr 68:971, 1966
Simons SM, Main CA, Yaish HM, Rutzky J: Idiopathic
thrombocytopenic purpura in children. Pediatrics 87:16, 1975
Benham ES, Taft LI: Idiopathic thrombocytopenic purpura in
children: Results of steroid therapy and splenectomy. Aust
Paediat J 8:311, 1972
Lammi AT, Lovric VA: Idiopathic thrombocytopenic purpura: An
epidemiologic study. Pediatrics 83:31, 1973
den Ottolander GJ, Gratama JW, deKoning J, Brand A: Long-term
follow-up study of 168 patients with immune thrombocytopenia.
Scand J Haematol 32:101, 1984
Hoyle C, Darbyshire P, Eden OB: Idiopathic thrombocytopenia in
childhood. Scott Med J 31:174, 1986
Zaki M, Hassanein AA, Khalil AF: Childhood idiopathic
thrombocytopenic purpura: Report of 60 cases from Kuwait. Journal
of Tropical Pediatrics 36:10, 1990
Robb LG, Tiedeman K: Idiopathic thrombocytopenic purpura:
Predictors of chronic disease. Arch Dis Child 65:502, 1990
Buchanan GR, Holtkamp CA: Prednisone therapy for children with
newly diagnosed idiopathic thrombocytopenic purpura. A randomized
clinical trial. Am J Pediatr Hematol Oncol 6:355, 1984
Sartorius JA: Steroid treatment of idiopathic thrombocytopenic
purpura in children. Preliminary results of a randomized
cooperative study. Am J Pediatr Hematol Oncol 6:165, 1984
Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S,
Barnard D, De Veber B, Gent M: A prospective, randomized trial of
high-dose intravenous immune globulin G therapy, oral prednisone
therapy, and no therapy in childhood acute immune
thrombocytopenic purpura. J Pediatr 123:989, 1993
Woerner SJ, Abildgaard CF, French BN: Intracranial hemorrhage
in children with idiopathic thrombocytopenic purpura. Pediatrics
67:453, 1981
Imbach P, d'Apuzzo V, Hirt A, Rossi E, Vest M, Barandun S,
Baumgartner C, Morell A, Schoni M, Wagner HP: High-dose
intravenous gammaglobulin for idiopathic thrombocytopenic purpura
in childhood. Lancet 1:1228, 1981
Tamary H, Kaplinsky C, Levy I, Cohen IJ, Yaniv I, Stark B,
Goshen Y, Zaizov R: Chronic childhood idiopathic thrombocytopenia
purpura: Long-term follow-up. Acta Paediatr 83:931, 1994
Reid MM: Chronic idiopathic thrombocytopenic purpura:
incidence, treatment, and outcome. Arch Dis Child 72:125, 1995
Halperin DS, Doyle JJ: Is bone marrow examination justified in
idiopathic thrombocytopenic purpura? Am J Dis Child 142:508, 1988
Najean Y, Lecompte T: Genetic thrombocytopenia with autosomal
dominant transmission: A review of 54 cases. Br J Haematol
74:203, 1990
Pearson HA: The spleen and disturbances of splenic function,
in Nathan DG, Oski FA (eds): Hematology of Infancy and Childhood.
Philadelphia, PA, Saunders, 1993, p 1058
McWilliams NB, Maurer HM: Acute idiopathic thrombocytopenic
purpura in children. Am J Hematol 7:87, 1979
Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E,
Milner R, Ali K, Barnard D, Bernstein M, Chan KW, Esseltine D,
DeVeber B, Israels S, Kobrinsky N, Luke B: Randomised trial of
intravenous immunoglobulin G, intravenous anti-D, and oral
prednisone in childhood acute immune thrombocytopenic purpura.
Lancet 344:703, 1994
Taub JW, Warrier I, Holtkamp C, Beardsley DS, Lusher JM:
Characterization of autoantibodies against the platelet
glycoprotein antigens IIb/IIIa in childhood idiopathic
thrombocytopenia purpura. Am J Hematol 48:104, 1995
Imbach P, Wagner HP, Berchtold W: Intravenous immunoglobulin
versus oral corticosteroids in acute immune thrombocytopenic
purpura in childhood. Lancet 2:464, 1985
Bellucci S, Charpak Y, Chastang C, Tobelem G: Low doses v
conventional doses of corticoids in immune thrombocytopenic
purpura (ITP): Results of a randomized clinical trial in 160
children, 223 adults. Blood 71:1165, 1988
Ozsoylu S, Irken G, Karabent A: High-dose intravenous
methylprednisolone for acute childhood idiopathic
thrombocytopenic purpura. Eur J Haematol 42:431, 1989
del Principe D, Menichelli A, Mori PG, De Mattia D, Mancuso G,
Carnelli V, Zanesco L, Jankovic M, Calmasini M, Amici A, Miano C,
Rosati D, Ciavarella G, Oddo G, Giulotto P, Masera G, Lanza T:
Phase II trial of methylprednisolone pulse therapy in childhood
chronic thrombocytopenia. Acta Haematol 77:226, 1987
van Hoff J, Ritchey AK: Pulse methylprednisolone therapy for
acute childhood idiopathic thrombocytopenic purpura. J Pediatr
113:563, 1988
Khalifa AS, Tolba KA, El-Alfy MS, Gadallah M, Ibrahim FH:
Idiopathic thrombocytopenic purpura in Egyptian children. Acta
Haematol 90:125, 1993
Ozsoylu S, Sayli TR, Ozturk G: Oral megadose
methylprednisolone versus intravenous immunoglobulin for acute
childhood idiopathic thrombocytopenic purpura. Pediatr Hematol
Oncol 10:317, 1993
Albayrak D, Islek I, Kalaycí AG, Gürses N: Acute immune
thrombocytopenic purpura: A comparative study of very high oral
doses of methylprednisolone and intravenously administered immune
globulin. J Pediatr 125:1004, 1994
Morris HG, Jorgensen JR, Elrick H, Goldsmith RE: Metabolic
effects of human growth hormone in corticosteroid-treated
children. J Clin Invest 47:436, 1968
Bussel JB, Schulman I, Hilgartner MW, Barandun S: Intravenous
use of gammaglobulin in the treatment of chronic immune
thrombocytopenic purpura as a means to defer splenectomy. J
Pediatr 103:651, 1983
Bussel JB, Goldman A, Imbach P, Schulman I, Hilgartner MW:
Treatment of acute idiopathic thrombocytopenia of childhood with
intravenous infusions of gammaglobulin. J Pediatr 106:886, 1985
Imholz B, Imbach P, Baumgartner C, Berchtold W, Gaedicke G,
Gugler E, Hirt A, Hitzig W, Mueller-Eckhardt C, Wagner HP:
Intravenous immunoglobuklin (i.v. IgG) for previously treated
acute or for chronic idiopathic thrombocytopenic purpura (ITP) in
childhood: A prospective multicenter study. Blut 56:63, 1988
Becker T, Kuenzlen E, Salama A, Mertens R, Kiefel V, Weib H,
Lampert F, Gaedicke G, Mueller-Eckhardt C: Treatment of childhood
idiopathic Eur J Pediatr 145:166, 1986
Andrew M, Blanchette VS, Adams M, Ali K, Barnard D, Chan KW,
DeVeber LB, Esseltine D, Israels S, Korbrinsky N, Luke B, Milner
RA, Woloski BMR, Vegh P: A multicenter study of the treatment of
childhood chronic idiopathic thrombocytopenic purpura with
anti-D. J Pediatr 120:522, 1992
Borgna-Pignatti C, Battisti L, Zecca M, Locatelli F: Treatment
of chronic childhood immune thrombocytopenic purpura with
intramuscular anti-D immunoglobulins. Br J Haematol 88:618, 1994
Grosfeld JL, Naffis D, Boles ET Jr, Newton WA Jr: The role of
splenectomy in neonatal idiopathic thrombocytopenic purpura. J
Pediatr Surg 5:166, 1970
Zarella JT, Martin LW, Lampkin BC: Emergency splenectomy for
idiopathic thrombocytopenic purpura in children. J Pediatr Surg
13:243, 1978
Gaston MH, Verter JI, Woods G, Pegelow G, Kellerher J,
Presbury G, Zarkowsky H: Prophylaxis with oral penicillin in
children with sickle cell anemia: A randomized trial. N Engl J
Med 314:1593, 1986
Hilgartner MW, Lanzkowsky P, Smith CH: The use of azathioprine
in refractory idiopathic thrombocytopenic purpura in children.
Acta Paediatr Scand 59:409, 1970
Weinblatt ME, Kochen J, Ortega J: Danazol for children with
immune thrombocytopenic purpura. Am J Dis Child 142:1317, 1988
Cohn RJ, Schwyzer R, Hesseling PB, Poole JE, Naidoo J, Van
Heerden C: [alpha]-Interferon therapy for severe chronic
idiopathic thrombocytopenic purpura in children. Am J Hematol
43:246, 1993
Burrows RF, Kelton JG: Fetal thrombocytopenia and its relation
to maternal thrombocytopenia. N Engl J Med 329:1463, 1993
Burrows RF, Kelton JG: Platelets and pregnancy. Chapter 4.
Current Obstetric Medicine 2:83, 1993
McCrae KR, Samuels P, Schreiber AD: Pregnancy-associated
thrombocytopenia: Pathogenesis and management. Blood 80:2697,
1992
Ballem PJ: Diagnosis and management of thrombocytopenia in
obstetric syndromes, in Sacher RA, Brecher ME (eds): Obstetric
Transfusion Practice. Bethesda, MD, American Association of Blood
Banks, 1993, p 49
Bartholomew JR, Bell WR, Kickler TM, Repke J: Abrupt reversal
of gestational autoimmune thrombocytopenia after delivery. A case
report. J Reprod Med 34:234, 1989
Rasmus KT, Rottman RL, Kotelko DM, Wright WC, Stone JJ,
Rosenblatt RM: Unrecognized thrombocytopenia and regional
anesthesia in parturients: a retrospective review. Obstet Gynecol
73:943, 1989
Scott JR, Cruikshank DP, Kochenour NK, Pitkin RM, Warenski JC:
Fetal platelet counts in the obstetric managment of immunologic
thrombocytopenic purpura. Am J Obstet Gynecol 136:495, 1980
Woon KY, Tan KL, Khoo PT: The newborn and maternal idiopathic
thrombocytopenic purpura. J Singapore Paed Soc 23:71, 1981
Aviles A, Conte G, Ambriz R, Sinco A, Pizzuto J: Table 1. Lack
of relation between maternal and neonatal platelet counts. N Engl
J Med 305:830, 1981 (abstr)
Karpatkin M, Porges RF, Karpatkin S: Platelet counts in
infants of women with autoimmune thrombocytopenia. Effect of
steroid administration to the mother. N Engl J Med 305:936, 1981
Cines DB, Dusak B, Tomaski A, Mennuit M, Schreiber AD: Immune
thrombocytopenic purpura and pregnancy. N Engl J Med 306:826,
1982
Kelton JG, Inwood MJ, Barr RM, Effer SB, Hunter D, Wilson WL,
Ginsburg DA: Fetus, placenta, and newborn. The prenatal
prediction of thrombocytopenia in infants of mothers with
clinically diagnosed immune thrombocytopenia. Am J Obstet Gynecol
144:449, 1982
Kessler I, Lancet M, Borenstein R, Berrebi A, Mogilner BM: The
obstetrical management of patients with immunologic
thrombocytopenic purpura. Int J Gynec Obstet 20:23, 1982
Logaridis TE, Doran TA, Scott JG, Gare DG, Comtesse C: The
effect of maternal steroid administration on fetal platelet count
in immunologic thrombocytopenic purpura. Management of pregnancy
and mode of delivery. Am J Obstet Gynecol 145:147, 1983
Pizzuto J, Aviles A, Niz J: Thrombocytopenia and infant
platelet count. Letter to the editor. Am J Obstet Gynecol
146:994, 1983
Rote NS, Nielsen KG, Neilson VD, Hill HR, Scott JR: Studies by
enzyme-linked immunosorbent assay (ELISA) of antiplatelet
antibody and transient neonatal thrombocytopenic purpura. Am J
Reprod Immunol 3:178, 1983
Scott JR, Rote NS, Cruikshank DP: Antiplatelet antibodies and
platelet counts in pregnancies complicated by autoimmune
thrombocytopenia purpura. Am J Obstet Gynecol 145:932, 1983
Laros RK, Kagan R: Route of delivery for patients with immune
thrombocytopenia purpura. Am J Obstet Gynecol 148:901, 1984
Karpatkin M: Clinical and laboratory observations.
Corticosteroid therapy in thrombocytopenic infants of women with
autoimmune thrombocytopenia. J Pediatr 105:623, 1984
Wahbeh CJ, Eden RD, Killam AP, Gall SA: Pregnancy and immune
thrombocytopenic purpura. Letter to the editor. Am J Obstet
Gynecol 149:238, 1984
Wenske G, Gaedicke G, Heyes H: Idiopathic thrombocytopenic
purpura in pregnancy and neonatal period. Blut 48:377, 1984
Barbui T, Cortelazzo S, Viero P, Buelli M, Casarotto C:
Idiopathic thrombocytopenic purpura and pregnancy. Maternal
platelet count and antiplatelet antibodies do not predict the
risk of neonatal thrombocytopenia. La Ricerca Clin Lab 15:139,
1985
Mazzucconi MG, Francesconi M, Fidani P, Conti L, Martelli MC,
Paesano R, Pachi' A: Pregnancy, delivery and detection of
antiplatelet antibodies in women with idiopathic thrombocytopenic
purpura. Haematologica 70:506, 1985
White R: Pregnancy complicated by immune thrombocytopenic
purpura. Ir Med J 80:97, 1987
Moise KJ Jr, Carpenter RJ Jr, Cotton DB, Wasserstrum N,
Kirshon B, Cano L: Percutaneous umbilical cord blood sampling in
the evaluation of fetal platelet counts in pregnant patients with
autoimmune thrombocytopenia purpura. Obstet Gynecol 72:346, 1988
Scioscia AL, Grannum AT, Copel JA, Hobbins JC: The use of
percutaneous umbilical blood sampling in immune thrombocytopenic
purpura. Am J Obstet Gynecol 159:1066, 1988
Tchernia G: Immune thrombocytopenia purpura and pregnancy.
Curr Stu Hematol Blood Transf 55:81, 1988
Ballem PJ, Buskard N, Wittman BK, Wilson RD, Effer S,
Farquharson D: ITP in pregnancy: Use of the bleeding time as an
indicator for treatment. Blut 59:132, 1989
Dan U, Barkai G, David B, Goldenberg M, Kukkia E, Mashiach S:
Management of labor in patients with idiopathic thrombocytopenic
purpura. Gynecol Obstet Invest 27:193, 1989
Burrows RF, Kelton JG: Thrombocytopenia at delivery: A
prospective survey of 6715 deliveries. Am J Obstet Gynecol
162:731, 1990
Christiaens GCML, Nieuwenhuis HK, von dem Borne AEGK, Ouwehand
WH,Helmerhorst FM, van Dalen CM, Van der Tweel I: Idiopathic
thrombocytopenic purpura in pregnancy: A randomized trial on the
effect of antenatal low dose corticosteroids on neonatal platelet
count. Br J Obstet Gynaecol 97:893, 1990
Kaplan C, Daffos F, Forestier F, Tertian G, Catherine N, Pons
JC, Tchernia G: Fetal platelet counts in thrombocytopenic
pregnancy. Lancet 336:979, 1990
Moutet A, Fromont P, Farcet J-P, Rotten D, Bettaieb A,
Duédari N, Bierling P: Pregnancy in women with immune
thrombocytopenic purpura. Arch Intern Med 150:2141, 1990
Samuels P, Bussel JB, Braitman LE, Tomaski A, Druzin ML,
Mennuti MT, Cines DB: Estimation of the risk of thrombocytopenia
in the offspring of pregnant women with presumed immune
thrombocytopenic purpura. N Engl J Med 323:229, 1990
Sharon R, Tatarsky I: Low fetal morbidity in pregnancy
associated with acute and chronic idiopathic thrombocytopenic
purpura. Am J Hematol 46:87, 1994
Burrows RF, Kelton JG: Pregnancy in patients with idiopathic
thrombocytopenic purpura: Assessing the risks for the infant at
delivery. Obstet Gynecol Survey 48:781, 1993
Browning J, James D: Immune thrombocytopenia in pregnancy.
Fetal Med Rev 2:143, 1990
Cook RL, Miller RC, Katz VL, Cefalo RC: Immune
thrombocytopenic purpura in pregnancy: A reappraisal of
management. Obstet Gynecol 78:578, 1991
Garmel SH, Craigo SD, Morin LM, Crowley JM, D'Alton ME: The
role of percutaneous umbilical blood sampling in the management
of immune thrombocytopenic purpura. Prenatal Diagnosis 15:439,
1995
Daffos F, Capella-Pavlovsky M, Forestier F: Fetal blood
sampling during pregnancy with the use of a needle guided by
ultrasound: A study of 606 consecutive cases. Am J Obstet Gynecol
153:655, 1985
Pielet BW, Socol ML, MacGregor SN, Ney JA, Dooley SL:
Cordocentesis: An appraisal of risks. Am J Obstet Gynecol
159:1497, 1988
Paidas MJ, Berkowitz RL, Lynch L, Lockwood CJ, Lapinski R,
McFarland JG, Bussel JB: Alloimmune thrombocytopenia: Fetal and
neonatal losses related to cordocentesis. Am J Obstet Gynecol
172:475, 1995
Christiaens GCML, Helmerhorst FM: Validity of intrapartum
diagnosis of fetal thrombocytopenia. Am J Obstet Gynecol 157:864,
1987
Burrows RF, Kelton JG: Low fetal risks in pregnancies
associated with idiopathic thrombocytopenic purpura. Am J Obstet
Gynecol 163:1147, 1990
Adams DM, Bussel JB, Druzin ML: Accurate intrapartum
estimation of fetal platelet count by fetal scalp sample smear.
Am J Perinatol 11:42, 1994
Rayburn WF: Glucocorticoid therapy for rheumatic diseases:
Maternal, fetal, and breast-feeding considerations. Am J Reprod
Immunol 28:138, 1992
Mulvihill JJ, McKeen EA, Rosner F, Zarrabi MH: Pregnancy
outcome in cancer patients. Experience in a large cooperative
group. Cancer 60:1143, 1987
Garber JE: Long-term follow-up of children exposed to utero to
antieoplastic agents. Semin Oncol 16:437, 1989
Ostensen M: Treatment with immunosuppressive and disease
modifying drugs during pregnancy and lactation. Am J Reprod
Immunol 28:148, 1992
Andrew M, Castle V, Salgal S, Carter C, Kelton JG: Clinical
impact of neonatal thrombocytopenia. J Pediat 110:457, 1987
Ballin A, Andrew M, Ling E, Perlman M, Blanchette V: High-dose
intravenous gammaglobulin therapy for neonatal autoimmune
thrombocytopenia. J Pediatr 112:789, 1988
Hirsch EO, Dameshek W: "Idiopathic"
thrombocytopenia. Review of eighty-nine cases with particular
reference to the differentiation and treatment of acute
(self-limited) and chronic types. Arch Intern Med 88:701, 1951
Lacey JV, Penner JA: Management of idiopathic thrombocytopenic
purpura in the adult. Semin Thromb Hemost 3:160, 1977
Slichter SL, Harker LA: Thrombocytopenia: Mechanisms and
management of defects in platelet production. Clin Haematol
7:523, 1978
Gmur J, Burger J, Schanz U, Fehr J, Schaffner A: Safety of
stringent prophylactic platelet transfusion policy for patients
with acute leukemia. Lancet 338:1223, 1991
Lawrence JB, Yomtovian RA, Dillman C, Masarik SR,
Chongkolwatana V, Creger RJ, Manka A, Hammons T, Lazarus HM:
Reliability of automated platelet counts: Comparison with manual
method and utility for prediction of clinical bleeding. Am J
Hematol 48:244, 1995
Schattner E, Bussel J: Mortality in immune thrombocytopenic
purpura: Report of seven cases and consideration of prognostic
indicators. Am J Hematol 46:120, 1994
Mazzucconi MG, Francesconi M, Fidani P, Nucci GD, Gandolfo GM,
Afeltra A, Masala C, Prima MD, Rocchi G, Resta S, Mandelli F:
Treatment of idiopathic thrombocytopenic purpura: results of a
multicentric protocol. Haematologia 70:329, 1985
Guthrie TH, Brannan DP, Prisant LM: Idiopathic
thrombocytopenic purpura in the older adult patient. Am J Med Sci
296:17, 1988
Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui
T: High risk of severe bleeding in aged patients with chronic
idiopathic thrombocytopenic purpura. Blood 77:31, 1991
Watson-Williams EJ, Macpherson AIS, Davidson S: The treatment
of idiopathic thrombocytopenic purpura. Lancet 2:221, 1958
Carpenter AF, Wintrobe MM, Fuller EA, Haut A, Cartwright GE:
Treatment of idiopathic thrombocytopenic purpura. JAMA 171:1911,
1959
Thompson RL, Moore RA, Hess CE, Wheby MS, Leavell BS:
Idiopathic thrombocytopenic purpura. Arch Intern Med 130:730,
1972
Meyers MC: Results of treatment in 71 patients with idiopathic
thrombocytopenic purpura. Am J Med Sci 242:295, 1961JiJi RM,
Firozvi T, Spurling CL: Chronic idiopathic thrombocytopenic
purpura. Arch Intern Med 132:380, 1973
Picozzi VJ, Roeske WR, Creger WP: Fate of therapy failures in
adult idiopathic thrombocytopenic purpura. Am J Med 69:690, 1980
Ikkala E, Kivilaakso E, Kotilainen M, Hastbacka J: Treatment
of idiopathic thrombocytopenic purpura in adults. Ann Clin Res
10:83, 1978
DiFino SM, Lachant NA, Kirshner JJ, Gottlieb AJ: Adult
idiopathic thrombocytopenic purpura. Clinical findings and
response to therapy. Am J Med 69:430, 1980
Jacobs P, Wood L, Dent DM: Results of treatment in immune
thrombocytopenia. Quart J Med 226:153, 1986
Pizzuto J, Ambriz R: Therapeutic experience on 934 adults with
idiopathic thrombocytopenic purpura: multicentric trial of the
cooperative Latin American group on hemostasis and thrombosis.
Blood 64:1179, 1984
Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D,
Stolley PD, Shapiro S: Acute thrombocytopenic purpura in relation
to the use of drugs. Blood 82:2714, 1993
Doan CA, Bouroncle BA, Wiseman BK: Idiopathic and secondary
thrombocytopenic purpura: Clinical study and evaluation of 381
cases over a period of 28 years. Ann Intern Med 53:861, 1960
Wanachiwanawin W, Visudhiphan S, Piankijagum A, Vatanavicharn
S: Serious complications following treatment of chronic
idiopathic thrombocytopenic purpura. Postgrad Med J 64:426, 1988
Warrier IA, Lusher JM: Intravenous gammaglobulin (gamimune)
for treatment of chronic idiopathic thrombocytopenic purpura
(ITP): A two-year follow-up. Am J Hematol 23:323, 1986
Bussel JB, Fitzgerald-Pederson J, Feldman C: Alternation of
two doses of intravenous gammaglobulin in the maintenance
treatment of patients with immune thrombocytopenic purpura: More
is not always better. Am J Hematol 33:184, 1990
Duhem C, Dicato MA, Ries F: Side-effects of intravenous immune
globulins. Clin Exp Immunol 97:79, 1994 (suppl 1)
Sekul EA, Cupler EJ, Dalakas MC: Aseptic meningitis associated
with high-dose intravenous immunoglobulin therapy: Frequency and
risk factors. Ann Intern Med 121:259, 1994
Thomas MJ, Misbah SA, Chapel HM, Jones M, Elrington G,
Newsom-Davis J: Hemolysis after high-dose intravenous Ig. Blood
82:3789, 1993
Centers for Disease Control and Prevention: Outbreak of
hepatitis C associated with intravenous immunoglobulin
administration--United States, October 1993-June 1994. MMWR Morb
Mortal Wkly Rep 43:505, 1994
Bjoro K, Froland SS, Yun Z, Samdal H, Haaland T: Hepatitis C
infection in patients with primary hypogammaglobulinemia after
treatment with contaminated immune globulin. New Eng J Med
331:1607, 1994
Yu MW, Mason BL, Guo ZP, Tankersley DL, Nedjar S, Mitchell FD,
Biswas RM: Hepatitis C transmission associated with intravenous
immunoglobulins. Lancet 345:1173, 1995
Schiano TD, Bellary SV, Black M: Possible transmission of
hepatitis C virus infection with intravenous immunoglobulin. Ann
Int Med 122:802, 1995
Bierling P, Farcet JP, Dvedari N, Rochant H: Gamma globulin
for idiopathic thrombocytopenic purpura. N Engl J Med 307:1150,
1982
Newland AC, Treleaven JG, Minchinton RM, Waters AH: High-dose
intravenous IgG in adults with autoimmune thrombocytopenia.
Lancet 1:84, 1983
Solal-Celigny P, Bernard JF, Herrera A, Boivin P: Treatment of
adult autoimmune thrombocytopenic purpura with high-dose
intravenous plasmin-cleaved gammaglobulins. Scand J Haematol
31:39, 1983
Abe T, Matsuda J, Kawasugi K, Yoshimura Y, Kinoshita T, Kazama
M: Clinical effects of intravenous immunoglobulin on chronic
idiopathic thrombocytopenic purpura. Blut 47:69, 1983
Kurata Y, Tsubakio T, Yonezawa T, Tarui S: High-dose
gammaglobulin therapy for idiopathic thrombocytopenic purpura in
adults. Acta Haematol 69:391, 1983
Carroll RR, Noyes WD, Rosse WF, Kitchens CS: Intravenous
immunoglobulin administration in the treatment of severe chronic
immune thrombocytopenic purpura. Am J Med 76:181, 1984
Oral A, Nusbacher J, Hill JB, Lewis JH: Intravenous gamma
globulin in the treatment of chronic idiopathic thrombocytopenic
purpura in adults. Am J Med 187, 1984
Uchino H, Yasunaga K, Akatsuka J: A cooperative clinical trial
of high-dose immunoglobulin therapy in 177 cases of idiopathic
thrombocytopenic purpura. Thromb Haemost 51:182, 1984
Schmidt RE, Budde U, Broschen-Zywietz C, Schafer G,
Mueller-Eckhardt C: High dose gammaglobulin therapy in adults
with idiopathic thrombocytopenic purpura (ITP) clinical effects.
Blut 48:19, 1984
Lang JM, Faradji A, Giron C, Bergerat JP, Oberling F:
High-dose intravenous IgG for chronic idiopathic thrombocytopenic
purpura in adults. Blut 49:95, 1984
Kurlander R, Coleman RE, Moore J, Gockerman J, Rosse W, Siegal
R: Comparison of the efficacy of a two-day and a five-day
schedule for infusing intravenous gamma globulin in the treatment
of immune thrombocytopenic purpura in adults. Amer J Med 83:17,
1987 (suppl 4A)
Bussel JB, Pham LC, Aledort L, Nachman R: Maintenance
treatment of adults with chronic refractory immune
thrombocytopenic purpura using repeated intravenous infusions of
gammaglobulin. Blood 72:121, 1988
Rodeghiero F, Schiavotto C, Castaman G, Vespignani M, Ruggeri
M, Dini E: A follow-up study of 49 adult patients with idiopathic
thrombocytopenic purpura treated with high-dose immunoglobulins
and anti-D immunoglobulins. Haematologia 77:248, 1992
Godeau B, Lesage S, Divine M, Wirquin V, Farcet JP, Bierling
P: Treatment of adult chronic autoimmune thrombocytopenic purpura
with repeated high-dose intravenous immunoglobulin. Blood
82:1415, 1993
Tan E, Hajinazarian M, Bay W, Neff J, Mendell JR: Acute renal
failure resulting from intravenous immunoglobulin therapy. Arch
Neurol 50:137, 1993
Ruggeri M, Castaman G, De Nardi G, Rodeghiero F: Acute renal
failure after high-dose intravenous immune globulin in a patient
with idiopathic thrombocytopenic purpura. Haematologica 78:338,
1993
Rault R, Piraino B, Johnston JR, Oral A: Pulmonary and renal
toxicity of intravenous immunoglobulin. Clin Nephrol 36:83, 1991
Woodruff RK, Grigg AP, Firkin FC, Smith IL: Fatal thrombotic
events during treatment of autoimmune thrombocytopenia with
intravenous immunoglobulin in elderly patients. Lancet 2:217,
1986
Dalakas MC: High-dose intravenous immunoglobulin and serum
viscosity: Risk of precipitating thromboembolic events. Neurology
44:223, 1994
Salama A, Mueller-Eckhardt C, Kiefel V: Effect of intravenous
immunoglobulin in immune thrombocytopenia. Competitive inhibition
of reticuloendothelial system function by sequestration of
autologous red blood cells? Lancet 2:193, 1983
Ginsberg JS, Brill-Edwards P, Kowalchuk G, Hirsh J:
Intermittent compression units for the postphlebitic syndrome. A
pilot study. Arch Intern Med 149:1651, 1989
Escolar G, Cases A, Monteagudo J, Garrido M, Lopez J, Ordinas
A, Revert L, Castillo R: Uremic plasma after infusion of
desmopression (DDAVP) improves the interaction of normal
platelets with vessel subendothelium. J Lab Clin Med 114:36, 1989
Law C, Marcaccio M, Tam P, Heddle N,
Kelton JG: High-dose intravenous immune globulin and the response
to splenectomy in patients with idiopathic thrombocytopenic
purpura N Engl J. Med 336 (21):1494, 1997
Brooks PL, O'Shea MJ, Pryor JP: Splenectomy in the treatment
of idiopathic thrombocytopenic purpura. Br J Surg 56:861, 1969
Davis PW, Williams DA, Shamberger RC: Immune thrombocytopenia:
Surgical therapy and predictors of response. J Pediatr Surg
26:407, 1991
Styrt B: Infection associated with asplenia: Risks,
mechanisms, and prevention. Am J Med 88:5-33N, 1990
Lortan JE: Clinical annotation. Management of asplenic
patients. Br J Haematol 84:566, 1993
Schilling RF: Estimating the risk for sepsis after splenectomy
in hereditary spherocytosis. Ann Intern Med 122:187, 1995
McIntyre OR, Ebaugh FGJ: Palpable spleens in college freshmen.
Ann Intern Med 66:301, 1967
Whipple AO: Splenectomy as a therapeutic measure in
thrombocytopenic purpura haemorrhagica. Surg Gynecol Obstet
42:329, 1926
Block GE, Evans R, Zajtchuk R: Splenectomy for idiopathic
thrombocytopenic purpura. Arch Surg 92:484, 1966
Wilde RC, Ellis LD, Cooper WM: Splenectomy for chronic
idiopathic thrombocytopenic purpura. Arch Surg 95:344, 1967
Charlesworth D, Torrance HB: Splenectomy in idiopathic
thrombocytopenic purpura. Br J Surg 55:437, 1968
Brennan MF, Rappeport JM, Moloney WC, Wilson RE: Correlation
between response to corticosteroids and splenectomy for adult
thrombocytopenic purpura. Am J Surg 129:490, 1975
Schwartz SI, Hoepp LM, Sachs S: Splenectomy for
thrombocytopenia. Surgery 88:497, 1980
Gruenberg JC, Block MA, Van Slyck EJ, Abraham JP: Chronic
idiopathic thrombocytopenic purpura. Effective preoperative
preparation and long-term results of splenectomy. Henry Ford Hosp
Med J 30:59, 1982
Musser G, Lazar G, Hocking W, Busuttil RW: Splenectomy for
hematologic disease. The UCLA experience with 306 patients. Ann
Surg 200:40, 1984
Salky B, Katsoyannis G, Aufses AH, Jr., Kreel I: Splenectomy
for chronic idiopathic thrombocytopenic purpura. Mount Sinai J
Med 51:287,1984
Rocco MV, Stein RS: Prognostic factors for splenectomy
response in adult idiopathic thrombocytopenic purpura. Southern
Med J 77:983, 1984
Boughton BJ, Smith P, Fielding J, Hawker R, Wilson I, Chandler
S, Howie A: Size of spleen rather than amount of platelet
sequestration may determine long term response to splenectomy in
adult idiopathic thrombocytopenic purpura. J Clin Path 38:1172,
1985
Cola B, Tonielli E, Sacco S, Brulatti M, Franchini A: Surgical
treatment of chronic idiopathic thrombocytopenic purpura. Results
in 107 cases. Int Surg 71:195, 1986
Coon WW: Splenectomy for idiopathic thrombocytopenic purpura.
Sur Gynecol Obstet 164:225, 1987
Akwari OE, Itani KMF, Coleman RE, Rosse WF: Splenectomy for
primary and recurrent immune thrombocytopenic purpura. Ann Surg
206:529, 1987
Wanachiwanawin W, Piankijagum A, Sindhvananda K, Vathanophas
V, Visudhiphan S, Na-Nakorn S: Emergency splenectomy in adult
idiopathic thrombocytopenic purpura. A report of seven cases.
Arch Intern Med 149:217, 1989
Fabris F, Zanatta N, Casonato A, Randi ML, Luzzatto G,
Girolami A: Response to splenectomy in idiopathic
thrombocytopenic purpura: prognostic value of the clinical and
laboratory evaluation. Acta Haematol 81:28, 1989
Shaw JHF, Clark MA: Splenectomy for immune thrombocytopenic
purpura: Auckland experience 1979-1987. Aust NZ J Surg 59:123,
1989
Fenaux P, Caulier MT, Hirschauer C, Beuscart R, Goudemand J,
Bauters F: Reevaluation of the prognostic factors for splenectomy
in chronic idiopathic thrombocytopenic purpura (ITP): A report on
181 cases. Eur J Haematol 42:259, 1989
Julia A, Araguas C, Rossello J, Bueno J, Domenech P, Olona M,
Guardia R, Petit J, Flores A: Lack of useful clinical predictors
of response to splenectomy in patients with chronic idiopathic
thrombocytopenic purpura. Br J Haematol 76:250, 1990
Naouri A, Feghali B, Chabal J, Boulez J, Dechavanne M, Viala
JJ, Tissot E: Results of splenectomy for idiopathic
thrombocytopenic purpura. Review of 72 cases. Acta Haematol
89:200, 1993
Rattner DW, Ellman L, Warshaw AL: Portal vein thrombosis after
elective splenectomy: An underappreciated, potentially lethal
syndrome. Arch Surg 128:565, 1993
Petit P, Bret PM, Atri M, Hreno A, Casola G, Gianfelice D:
Splenic vein thrombosis after splenectomy: Frequency and role of
imaging. Radiology 190:65, 1994
Verheyden CN, Beart RW, Clifton MD, Phyliky RL: Accessory
splenectomy in management of recurrent idiopathic
thrombocytopenic purpura. Mayo Clin Proc 53:442, 1978
Pawelska S, Konopka L, Zdziechowska H: Recurrence of
thrombocytopenia in patients splenectomized for idiopathic
thrombocytopenic purpura. Blut 43:355, 1981
Rudowski WJ: Accessory spleens: clinical significance with
particular reference to the recurrence of idiopathic
thrombocytopenic purpura. World J Surg 9:422, 1985
Wallace D, Fromm D, Thomas D: Accessory splenectomy for
idiopathic thrombocytopenic purpura. Surgery 91:134, 1982
Ambriz R, Munoz R, Quintanar E, Sigler L, Aviles A, Pizzuto J:
Accessory spleen compromising response to splenectomy for
idiopathic thrombocytopenic purpura. Radiology 155:793, 1985
Gibson J, Rickard KA, Bautovich G, May J, Kronenberg H:
Management of splenectomy failures in chronic immune
thrombocytopenic purpura: role of accessory splenectomy. Aust N Z
J Med 16:695, 1986
Facon T, Caulier MT, Fenaux P, Plantier I, Marchandise X,
Ribet M, Jouet JP, Bauters F: Accessory spleen in recurrent
chronic immune thrombocytopenic purpura. Am J Hematol 41:184,
1992
Chirletti P, Cardi M, Barillari P, Vitale A, Sammartino P,
Bolognese A, Caiazzo R, Ricci M, Muttillo IA, Stipa V: Surgical
treatment of immune thrombocytopenic purpura. World J Surg
16:1001, 1992
von dem Borne AEGK, Vos JJE, Pegels JG, Thomas LLM, van der
Lelie H: High dose intravenous methylprednisolone or high dose
intravenous gammaglobulin for autoimmune thrombocytopenia. Br Med
J 296:249, 1988
Godeau B, Zini J-M, Schaeffer A, Bierling P: High-dose
methylprednisolone is an alternative treatment for adults with
autoimmune thrombocytopenic purpura refractory to intravenous
immunoglobulins and oral corticosteroids. Am J Hematol 48:282,
1995
Jacobs P, Wood L, Novitzky N: Intravenous gammaglobulin has no
advantages over oral corticosteroids as primary therapy for
adults with immune thrombocytopenia: A prospective randomized
clinical trial. Am J Med 97:55, 1994
Laan RFJM, va Riel PLCM, van de Putte LBA, van Erning LJTO,
van't Hof MA, Lemmens JAM: Low-dose prednisone induces rapid
reversible axial bone loss in patients with rheumatoid arthritis.
A randomized, controlled study. Ann Intern Med 119:963, 1993
Bouroncle BA, Doan CA: Treatment of refractory idiopathic
thrombocytopenic purpura. JAMA 207:2049, 1969
Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF,
Zimmerman B, Kohler JA, Furst DE: Low dose long-term
corticosteroid therapy in rheumatoid arthritis: an analysis of
serious adverse effects. Am J Med 96:115, 1994
Bussel JB, Graziano JN, Kimberly RP, Pahwa S, Aledort LM:
Intravenous anti-D treatment of immune thrombocytopenic purpura:
Analysis of efficacy, toxicity, and mechanism of effect. Blood
77:1884, 1991
Reiquam CW, Prosper JC: Fresh plasma transfusions in the
treatment of acute thrombocytopenic purpura. J Pediatr 68:880,
1966
Salama A, Kiefel V, Amberg R, Mueller-Eckhardt C: Treatment of
autoimmune thrombocytopenic purpura with Rhesus antibodies
(anti-Rho(D)). Blut 49:29, 1984
Salama A, Kiefel V, Mueller-Eckhardt C: Effect of IgG
anti-Rho(D) in adult patients with chronic autoimmune
thrombocytopenia. Am J Hematol 22:241, 1986
Boughton BJ, Chakraverty R, Baglin TP, Simpson A, Galvin G,
Rose P, Rohlova B: The treatment of chronic idiopathic
thrombocytopenia with anti-D(Rho) immunoglobulin: its
effectiveness, safety and mechanism of action. Clin Lab Haematol
10:275, 1988
van Geet C, Hauglustaine D, Vanrusselt M, Vermylen J:
Haemostatic effects of recombinant human erythropoietin in
chronic haemodialysis patients. Thromb Haemost 61:117, 1989
Catovsky D, Fooks J, Richards S: Prognostic factors in chronic
lymphocytic leukaemia: The importance of age, sex and response to
treatment in survival. A report from the MRC CLL 1 trial. Br J
Haematol 72:141, 1989
Calverley DC, Jones GW, Kelton JG: Splenic radiation for
corticosteroid-resistant immune thrombocytopenia. Ann Int Med
116:977, 1992
Caulier MT, Darloy F, Rose C, Camier G, Morel P, Bauters F,
Fenaux P: Splenic irradiation for chronic autoimmune
thrombocytopenic purpura in patients with contra-indications to
splenectomy. Br J Haematol 91:208, 1995
Miyazaki M, Itoh H, Kaiho T, Ohtawa S, Ambiru S, Hayashi S,
Nakajima N, Oh H, Asai T, Iseki T: Partial splenic embolization
for the treatment of chronic idiopathic thrombocytopenic purpura.
Am J Roentgenol 163:123, 1994
Bouroncle BA, Doan CA: Refractory idiopathic thrombocytopenic
purpura treated with azathioprine. N Engl J Med 275:630, 1966
Sussman LN: Azathioprine in refractory idiopathic
thrombocytopenic purpura. JAMA 202:259, 1967
Quiquandon I, Fenaux P, Caulier MT, Pagniez D, Huart JJ,
Bauters F: Re-evaluation of the role of azathioprine in the
treatment of adult chronic idiopathic thrombocytopenic purpura: A
report on 53 cases. Br J Haematol 74:223, 1990
Kyle RA, Gertz MA: Second malignancies after chemotherapy, in
Perry MC (ed): The Chemotherapy Sourcebook. Baltimore, MD,
Williams and Wilkins, 1992, p 689
Doll DC, Ringenberg QS, Yarbo JW: Antineoplastic agents and
pregnancy. Semin Oncol 16:337, 1989
Laros RK, Penner JA: "Refractory" thrombocytopenic
purpura treated successfully with cyclophosphamide. JAMA 215:445,
1971
Verlin M, Laros RK, Penner JA: Treatment of refractory
thrombocytopenic purpura with cyclophosphamide. Am J Hematol
1:97, 1976
Weinerman B, Maxwell I, Hryniuk W: Intermittent
cyclophosphamide treatment of autoimmune thrombocytopenia. Can
Med Assoc J 111:1100, 1974
Srichaikul T, Boonpucknavig S, Archararit N,
Chaisiri-pumkeeree W: Chronic immunologic thrombocytopenic
purpura. Results of cyclophosphamide therapy before splenectomy.
Arch Intern Med 140:636, 1980
Reiner A, Gernsheimer T, Slichter SJ: Pulse cyclophosphamide
therapy for refractory autoimmune thrombocytopenic purpura. Blood
85:351, 1995
Smith AG, Prentice AG, Lucie NP, Browning JD, Dagg JH, Rowan
RM: Acute myelogenous leukaemia following cytotoxic therapy: five
cases and a review. Quart J Med 51:227, 1982
Krause JR: Chronic idiopathic thrombocytopenic purpura (ITP):
development of acute nonlymphocytic leukemia subsequent to
treatment with cyclophosphamide. Med Pediatr Oncol 10:61, 1982
Ahn YS, Harrington WJ, Seelman RC, Eytel CS: Vincristine
therapy of idiopathic and secondary thrombocytopenias. N Engl J
Med 291:376, 1974 &cmd[;jf51&cmd];
Burton IE, Roberts BE, Child JA, Montgomery DA, Raper CGL:
Responses to vincristine in refractory idiopathic
thrombocytopenic purpura. Br Med J 2:918, 1976
Ahn YS, Byrnes JJ, Harrington WJ, Cayer ML, Smith DS,
Brunskill DE, Pall LM: The treatment of idiopathic
thrombocytopenia with vinblastine-loaded platelets. N Engl J Med
298:1101, 1978
Cervantes F, Rozman C, Feliu E, Montserrat E, Diumenjo C,
Granena A: Low-dose vincristine in the treatment of
corticosteroid-refractory idiopathic thrombocytopenic purpura
(ITP) in non-splenectomized patients. Postgrad Med J 56:711, 1980
Kelton JG, McDonald JWD, Barr RM, Walker I, Nicholson W, Neame
PB, Hamid C, Wong TY, Hirsh J: The reversible binding of
vinblastine to platelets: implications for therapy. Blood 57:431,
1981
Ahn YS, Harrington WJ, Mylvaganam R, Allen LM, Pall LM: Slow
infusion of vinca alkaloids in the treatment of idiopathic
thrombocytopenic purpura. Ann Intern Med 100:192, 1984
Manoharan A: Slow infusion of vincristine in the treatment of
idiopathic thrombocytopenic purpura. Am J Hematol 21:135, 1986
Simon M, Jouet J, Fenaux P, Pollet J, Walter M, Bauters F: The
treatment of adult idiopathic thrombocytopenic purpura. Infusion
of vinblastine in ITP. Eur J Haematol 39:193, 1987
Linares M, Cervero A, Sanchez M, Garcia S, Miguel-Sosa A,
Miguel-Garcia A, Miguel-Borja JM: Slow infusion of vincristine in
the treatment of refractory thrombocytopenic purpura. Acta
Haematol 80:173, 1988
Fenaux P, Quiquandon I, Caulier MT, Simon M, Walter MP,
Bauters F: Slow infusions of vinblastine in the treatment of
adult idiopathic thrombocytopenic purpura: a report on 43 cases.
Blut 60:238, 1990
Manoharan A: Targeted-immunosuppression with vincristine
infusion in the treatment of immune thrombocytopenia. Aust NZ J
Med 21:405, 1991
Facon T, Caulier MT, Wattel E, Jouet JP, Bauters F, Fenaux P:
A randomized trial comparing vinblastine in slow infusion and by
bolus i.v. injection in idiopathic thrombocytopenic purpura: A
report on 42 patients. Br J Haematol 86:678, 1994
Ahn YS, Harrington WJ, Simon SR, Mylvaganam R, Pall LM, So AG:
Danazol for the treatment of idiopathic thrombocytopenic purpura.
N Engl J Med 308:1396, 1983
Buelli M, Cortelazzo S, Viero P, Minetti B, Comotti B, Bassan
R, Barbui T: Danazol for the treatment of idiopathic
thrombocytopenic purpura. Acta Haematol 74:97, 1985
McVerry BA, Auger M, Bellingham AJ: The use of danazol in the
management of chronic immune thrombocytopenic purpura. Br J
Haematol 61:145, 1985
Almagro D: Danazol in idiopathic thrombocytopenic purpura.
Acta Haematol 74:120, 1985
Ambriz R, Pizzuto J, Morales M, Chavez G, Guillen C, Aviles A:
Therapeutic effect of danazol on metrorrhagia in patients with
idiopathic thrombocytopenic purpura (ITP). Nouv Rev Fr Hematol
28:275, 1986
Mazzucconi MG, Francesconi M, Falcione E, Ferrari A, Gandolfo
GM, Ghiradini A, Tirindelli MC: Danazol therapy in refractory
chronic immune thrombocytopenic purpura. Acta Haematol 77:45,
1987
Manoharan A: Danazol therapy in patients with immune
cytopenias. Aust NZ J Med 17:613, 1987
Schreiber AD, Chien P, Tomaski A, Cines DB: Effect of danazol
in immune thrombocytopenic purpura. N Engl J Med 316:503, 1987
Kotlarek-Haus S, Podolak-Dawidziak M: Danazol in chronic
idiopathic thrombocytopenic purpura resistant to corticosteroids.
Folia Haematol 114:768, 1987
Ahn YS, Mylvaganam R, Garcia RO, Kim CI, Palow D, Harrington
WJ: Low-dose danazol therapy in idiopathic thrombocytopenic
purpura. Ann Intern Med 107:177, 1987
Nalli G, Sajeva MR, Maffe GC, Ascari E: Danazol therapy for
idiopathic thrombocytopenic purpura (ITP). Haematologia 73:55,
1988
Ahn YS, Rocha R, Mylvaganam R, Garcia R, Duncan R, Harrington
WJ: Long-term danazol therapy in autoimmune thrombocytopenia:
unmaintained remission and age-dependent response in women. Ann
Intern Med 111:723, 1989
Edelmann DZ, Knobel B, Virag I, Meytes D: Danazol in
non-splenectomized patients with refractory idiopathic
thrombocytopenic purpura. Postgrad Med J 66:827, 1990
Flores A, Carles J, Junca J, Abella E: Danazol therapy in
chronic immume thrombocytopenic purpura. Eur J Haematol 45:109,
1990
Arrowsmith JB, Dreis M: Thrombocytopenia after treatment with
Danazol. N Engl J Med 314:585, 1986
Rabinowe SN, Miller KB: Danazol-induced thrombocytopenia. Br J
Haematol 65:383, 1987
Laveder F, Marcolongo R, Zamboni S: Thrombocytopenic purpura
following treatment with danazol. Br J Haematol 90:970, 1995
Brox AG, Howson-Jan K, Fauser AA: Treatment of idiopathic
thrombocytopenic purpura with ascorbate. Br J Haematol 70:341,
1988
Toyama K, Ohyashiki K, Nehashi Y, Ohyashiki JH: Ascorbate for
the treatment of idiopathic thrombocytopenic purpura. Br J
Haematol 75:623, 1990
Win N, Matthey F, Davies SC: Ascorbate for the treatment of
idiopathic thrombocytopenic purpura. Br J Haematol 75:626, 1990
Verhoef GEG, Boonen S, Boogaerts MA: Ascorbate for the
treatment of refractory idiopathic thrombocytopenic purpura. Br J
Haematol 74:234,1990
Godeau B, Bierling P: Treatment of chronic autoimmune
thrombocytopenic purpura with ascorbate. Br J Haematol 75:289,
1990
Novitzky N, Wood L, Jacobs P: Treatment of refractory immune
thrombocytopenic purpura with ascorbate. South African Med J
81:44, 1992
Van der Beek-Boter JW, Van Oers MHJ, Von dem Borne AEGK,
Klaassen RJL: Ascorbate for the treatment of ITP. Eur J Haematol
48:61, 1992
Jubelirer SJ: Pilot study of ascorbic acid for the treatment
of refractory immune thrombocytopenic purpura. Am J Hematol
43:44, 1993
Strother SV, Zuckerman KS, LoBuglio AF: Colchicine therapy for
refractory idiopathic thrombocytopenic purpura. Arch Intern Med
144:2198, 1984
Jim RTS: Therapeutic use of colchicine in thrombocytopenia.
Hawaii Med J 45:221, 1986
Snyder HW, Cochran SK, Balint JP, Bertram JH, Mittelman A,
Guthrie TH, Jones FR: Experience with protein A-immunoadsorption
in treatment-resistant adult immune thrombocytopenic purpura.
Blood 79:2237, 1992
Balint JP Jr, Snyder HW Jr, Cochran SK, Jones FR: Long-term
responseof immune thrombocytopenia to extracorporeal
immunoadsorption. Lancet 337:1106, 1991
Guthrie TH, Oral A: Immunethromboctyopenia purpura: A pilot
study of staphylococcal protein A immunomodulation in refractory
patients. Semin Hematol 26:3, 1989
Kabisch A, Kroll H, Wedi B, Kiefel V, Pralle H,
Mueller-Eckhardt C: Severe adverse effects of protein A
immunoadsorption. Lancet 343:116, 1994
Dzik WH, Duncan LM: Case records of the Massachusetts General
Hospital. A 55-year-old woman with a skin rash and hemiparesis
after staphylococcal protein A column therapy. N Engl J Med
331:792, 1994
Marder VJ, Nusbacher J, Anderson FW: One-Year follow-up of
plasma exchange therapy in 14 patients with idiopathic
thrombocytopenic purpura. Transfusion 21:291, 1981
Blanchette VS, Hogan VA, McCombie NE, Drouin J, Bormanis JD,
Taylor R, Rock GA: Intensive plasma exchange therapy in ten
patients with idiopathic thrombocytopenic purpura. Transfusion
24:388, 1984
Bussel JB, Saal S, Gordon B: Combined plasma exchange and
intravenous gammaglobulin in the treatment of patients with
refractory immune thrombocytopenic purpura. Transfusion 28:38,
1988
Figueroa M, McMillan R: 2-chlorodeoxyadenosine in the
treatment of chronic refractory immune thrombocytopenic purpura.
Blood 81:348 1993
Figueroa M, Gehlsen J, Hammond D, Ondreyco S, Piro L, Pomeroy
T, Williams F, McMillan R: Combination chemotherapy in refractory
immune thrombocytopenic purpura. N Engl J Med 328:1226, 1993
Proctor SJ, Jackson G, Carey P, Stark A, Finney R, Saunders P,
Summerfield G, Maharaj D, Youart A: Improvement of platelet
counts in steroid-unresponsive idiopathic immune thrombocytopenic
purpura after short-course therapy with recombinant alpha 2b
interferon. Blood 74:1894, 1989
Proctor SJ: Alpha interferon therapy in the treatment of
idiopathic thrombocytopenic purpura. Eur J Cancer 27:S63, 1991
(suppl 4)
Bellucci S, Bordessoule D, Coiffier B, Tabah I: Interferon
alpha-2b therapy in adult chronic thrombocytopenic purpura (ITP).
Br J Haematol 73:578, 1989
Iannaccaro P, Molica S, Santoro R: Recombinant alpha-2b
interferon in refractory idiopathic immune thrombocytopenia. Eur
J Haematol 48:271, 1992
Dubbeld P, Hillen HFP, Schouten HC: Interferon treatment of
refractory idiopathic thrombocytopenic purpura (ITP). Eur J
Haematol 52:233, 1994
Matthey F, Ardeman S, Jones L, Newland AC: Bleeding in immune
thrombocytopenic purpura after alpha-interferon. Lancet 335:471,
1990
Hudson JG, Yates P, Scott GL: Further concern over use of
alpha-interferon in immune thrombocytopenic purpura. Br J
Haematol 82:630, 1992
Bartholomew JR, Salgia R, Bell WR: Control of bleeding in
patients with immune and nonimmune thrombocytopenia with
aminocaproic acid. Arch Intern Med 149:1959, 1989
|
